Vimarsana
Biggest News Aggregation in the World

Waxman Act News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Waxman Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Waxman Act Today - Breaking & Trending Today

10 Years after Actavis, the Cases that Follow Tell a Story | Haug Partners LLP - Vimarsana News

10 Years after Actavis, the Cases that Follow Tell a Story | Haug Partners LLP

I. Introduction - No pharmaceutical antitrust decision has had more impact than the Supreme Court’s 2013 decision in Federal Trade Commission v. Actavis, a decision which...

Status Of Reverse Payment Cases Against Pharmaceutical Companies - Patent - Vimarsana News

Status Of Reverse Payment Cases Against Pharmaceutical Companies - Patent

Reverse payment cases arise in the context of settlement agreements between brand-name pharmaceutical companies and generic drug manufacturers to resolve patent litigation under the Hatch-Waxman Act...

Source: mondaq.com
Guest Post -- Congressional Authority, Agency Discretion, and Legislative Rulemaking | McDonnell Boehnen Hulbert & Berghoff LLP - Vimarsana News

Guest Post -- Congressional Authority, Agency Discretion, and Legislative Rulemaking | McDonnell Boehnen Hulbert & Berghoff LLP

More than a decade ago Congress considered, and rejected, any standing requirements for post-grant proceedings. Congress could hardly have been more explicit. The provisions were...

U.S. gov't largely to blame for high drug prices: USA Today-Xinhua - Vimarsana News

U.S. gov't largely to blame for high drug prices: USA Today-Xinhua

U.S. gov't largely to blame for high drug prices: USA Today-

Why Biden's price controls won't work to drive down drug costs - Vimarsana News

Why Biden's price controls won't work to drive down drug costs

A lot of people, including President Joe Biden, blame 'corporate greed' for high prescription costs. But it's not that simple.